- $455.45m
- $464.79m
- $233.80m
Cerus Corp expected to post a loss of 3 cents a share - Earnings Preview
Brief: Cerus Q2 Operating Expenses USD 33.9 Million
Analysis: Crypto players ready wishlist for potential second Trump administration
Brief: Cerus Q1 Adjusted EBITDA USD -2.7 Million Vs. IBES Estimate USD -1.23 Million
Cerus Corp expected to post a loss of 5 cents a share - Earnings Preview
Brief: Cerus Announces US FDA Approval Of Extended Shelf Life For INTERCEPT Platelet Processing Sets
Cerus Corp reports results for the quarter ended in December - Earnings Summary
Brief: Cerus Corporation Announces Fourth Quarter And Full-Year 2023 Financial Results
Brief: Cerus Q4 Adjusted EBITDA USD 4.7 Million
Cerus Corp expected to post a loss of 2 cents a share - Earnings Preview
Brief: Cerus Q4 Revenue USD 46.8 Million Vs. IBES Estimate USD 51.2 Million
Cerus Corp reports results for the quarter ended in September - Earnings Summary
Brief: Cerus Q3 Revenue USD 47.3 Million Vs. IBES Estimate USD 42.5 Million
Cerus Corp expected to post a loss of 5 cents a share - Earnings Preview
Cerus Corp reports results for the quarter ended in June - Earnings Summary
Brief: Cerus Q2 Revenue USD 47.7 Million Vs. IBES Estimate USD 41.8 Million
Cerus Corp expected to post a loss of 6 cents a share - Earnings Preview
Brief: Cerus Corporation Announces Follow-On Award Of U.S. Department Of Defense Funding For Development Of Pathogen Reduced, Lyophilized Cryoprecipitate
U.S. RESEARCH ROUNDUP-Albemarle, Cable One, Southwest Airlines